| Literature DB >> 27505672 |
Young Chan Chae1, Valentina Vaira2, M Cecilia Caino1, Hsin-Yao Tang3, Jae Ho Seo1, Andrew V Kossenkov4, Luisa Ottobrini5, Cristina Martelli3, Giovanni Lucignani6, Irene Bertolini7, Marco Locatelli8, Kelly G Bryant1, Jagadish C Ghosh1, Sofia Lisanti1, Bonsu Ku9, Silvano Bosari7, Lucia R Languino10, David W Speicher11, Dario C Altieri12.
Abstract
Hypoxia is a universal driver of aggressive tumor behavior, but the underlying mechanisms are not completely understood. Using a phosphoproteomics screen, we now show that active Akt accumulates in the mitochondria during hypoxia and phosphorylates pyruvate dehydrogenase kinase 1 (PDK1) on Thr346 to inactivate the pyruvate dehydrogenase complex. In turn, this pathway switches tumor metabolism toward glycolysis, antagonizes apoptosis and autophagy, dampens oxidative stress, and maintains tumor cell proliferation in the face of severe hypoxia. Mitochondrial Akt-PDK1 signaling correlates with unfavorable prognostic markers and shorter survival in glioma patients and may provide an "actionable" therapeutic target in cancer.Entities:
Keywords: Akt; PDK1; hypoxia; metabolism; mitochondria; tumor cell proliferation
Mesh:
Substances:
Year: 2016 PMID: 27505672 PMCID: PMC5131882 DOI: 10.1016/j.ccell.2016.07.004
Source DB: PubMed Journal: Cancer Cell ISSN: 1535-6108 Impact factor: 31.743